K Number
K081640
Device Name
GIMMI ANEURYSM CLIPS AND APPLYING FORCEPS
Manufacturer
Date Cleared
2009-05-06

(329 days)

Product Code
Regulation Number
882.5200
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
Permanent GIMMI Aneurysm Clips (Yasargil) and vessel clips are intended for Permanent occlusion of blood vessels and cerebral aneurysms. Likewise, temporary permianent occlusion of blood vessel clips are intended for temporary occlusion Gilvilli Aneurysin Olips (Tabargi) and cerebral aneurysms. They are also intended to be applied exclusively with the corresponding Clip Appliers.
Device Description
GIMMI Aneurysm Clips and their Clip Applying Forceps are used for the occlusion of aneurysms. "Mini" and "Standard" Clips can only be applied with the according Applying forceps; these forceps are labelled with "Mini" or "Standard". Clips are available in different sizes and shapes, to have the right size and shape due to the size and shape of the aneurysm.
More Information

Not Found

Not Found

No
The summary describes mechanical clips and appliers for surgical use and makes no mention of AI or ML technology.

Yes
The device is intended for the permanent occlusion of blood vessels and cerebral aneurysms, which is a direct treatment of a disease or condition.

No
The device is described as an aneurysm clip intended for permanent occlusion of blood vessels and cerebral aneurysms, which is a therapeutic intervention, not a diagnostic one.

No

The device description clearly indicates physical components (clips and forceps) and their intended use in surgical procedures, not software.

No, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In Vitro Diagnostics are medical devices used to examine specimens taken from the human body (like blood, urine, or tissue) to provide information for diagnosis, monitoring, or screening.
  • Device Function: The provided description clearly states that the GIMMI Aneurysm Clips and vessel clips are intended for the permanent or temporary occlusion of blood vessels and cerebral aneurysms. This is a surgical intervention performed directly on the patient's body, not an analysis of a specimen outside the body.
  • Intended Use: The intended use is to physically block blood flow, which is a therapeutic action, not a diagnostic test.

Therefore, based on the provided information, this device falls under the category of a surgical implant or instrument, not an In Vitro Diagnostic.

N/A

Intended Use / Indications for Use

Permanent GIMMI Aneurysm Clips (Yasargil) and vessel clips are intended for permanent occlusion of blood vessels and cerebral aneurysms. Likewise, temporary GIMMI Aneurysm Clips (Yasargil) and vessel clips are intended for temporary occlusion of intra cranial blood vessels and cerebral aneurysms. They are also intended to be applied exclusively with the corresponding Clip Appliers.

Product codes (comma separated list FDA assigned to the subject device)

84 HCH, 84 HCI

Device Description

GIMMI Aneurysm Clips and their Clip Applying Forceps are used for the occlusion of aneurysms. "Mini" and "Standard" Clips can only be applied with the according Applying forceps; these forceps are labelled with "Mini" or "Standard". Clips are available in different sizes and shapes, to have the right size and shape due to the size and shape of the aneurysm.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

blood vessels and cerebral aneurysms, intra cranial blood vessels and cerebral aneurysms.

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Non-clinical testing demonstrated that the GIMMI Aneurysm Clip system is MR compatible. It can be scanned safely under the following conditions: Static magnetic field of 1.5 Tesla or less, Spatial gradient field of 3 Gaus/cm or less, Maximum whole-body-averaged specific absorption rate (SAR) of 0.03 W/kg for 10 minutes of scanning. In this non-clinical testing with duration of 10 minutes with EPI (endoplanar imaging) sequences, the GIMMI Aneurysm Clips system produced no temperature rise and no movement. The test was performed in a SIEMENS MAGNETOM MAESTRO CLASS SYMPHONY MR scanner with a field strength of 1.5 Tesla.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

Not Found

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 882.5200 Aneurysm clip.

(a)
Identification. An aneurysm clip is a device used to occlude an intracranial aneurysm (a balloonlike sac formed on a blood vessel) to prevent it from bleeding or bursting.(b)
Classification. Class II (performance standards).

0

Visual Features/ Traits

MAY - 6 2009

081640

The type of material is shown on the packaging label. PERMANENT aneurysm clips made of Titanium can be identified by spectral color (red or blue), TEMPORARY aneurysm clips made of Titanium are gold colored.

PERMANENT Aneurysm clips made of Phynox are of natural color. TEMPORAR Y aneurysm clips made of Phynox have gold plated springs and spring shanks.

All Clips and Applying Forceps are delivered non-sterile and they must be cleaned and sterilized before use according Operating Instructions. Clips and Applying forceps are autoclaveable.

The materials used have already been approved in different instruments and implants, containing Titanium and Phynox. The biocompatibility is given by use of these Clips for over 15 years for human applications.

Aneurysm Clips and Applying forceps are produced according to prevailing standards with the technological characteristics of each clip listed on its labelling.

5.8 Intended Use (807.92(a)(5))

Permanent GIMMI Aneurysm Clips (Yasargil) and vessel clips are intended for permanent occlusion of blood vessels and cerebral aneurysms. Likewise, temporary GIMMI Aneurysm Clips (Yasargil) and vessel clips are intended for temporary occlusion of intra cranial blood vessels and cerebral aneurysms. They are also intended to be applied exclusively with the corresponding Clip Appliers.

5.9 Industry Standards / Performance data (807.92 (d))

GIMMI GmbH certifies compliance with relevant ISO/EN/ASTM/AAMIANSI and other device-related standards that apply to the manufacture, packaging, labelling and reprocessing of subject devise including the validation of these processes.

5.10 Non-Clinical Test Results

Based on the equivalence in design and materials to predicate devices and their use since over 15 Years, performance testing was not warranted. The devices will meet the same criteria of Safety and Effectiveness as SE-Devices.

5.11 Bacterial Endotoxins Test

See tests enclosed, Test 063633-10-A and Test 063633-10-B

5.12 Information Bearing on the Safety and Effectiveness (807.92(b)(3))

GIMMI aneurysm clips have the same intended use as predicate devices. They are made of the same material and are produced to the same international and FDA-recognized standards. Slight modifications in design do not adversely affect the safety and effectiveness of these Devices.

In Summary, the

  • Intended Use

  • Performance Attributes

  • Materials and

  • V Basic Design

are identical and/or substantially equivalent to SE devices.

The results of design validation raise no new issues of safety and effectiveness.

1

5.5 Reason for Submission

Abbreviated 510(k).

5.6 Predicate Devices (807.92(a)(3))

  • Aesculap, Inc

  • Rebstock - Instrumente GmbH

  • V. Mueller Neuro/Spine

  • Cardinal Health

  • Medicon, E.G.

  • Kirwan Surgical Products, Inc

Plus a wide range of other manufacturers/distributors

5.7 Device Description (807.87(a)(4) + (6))

GIMMI Aneurysm Clips and their Clip Applying Forceps are used for the occlusion of aneurysms. "Mini" and "Standard" Clips can only be applied with the according Applying forceps; these forceps are labelled with "Mini" or "Standard".

K081640

Clips are available in different sizes and shapes, to have the right size and shape due to the size and shape of the aneurysm.

See item list section 12.

CT- & MR- Safety

GIMMI Aneurysm Clip is manufactured from Titanium acc. to ISO 5832-2 and ISO 5832-3 or Phynox implant steel according to ISO 5832-7.

Non- clinical testing has demonstrated that the GIMMI Aneurysm Clip system is MR compatible. It can be scanned safely under the following conditions:

  • Static magnetic field of 1.5 Tesla or less

  • Spatial gradient field of 3 Gaus/cm or less

  • Maximum whole-body-averaged specific absorption rate (SAR) of 0.03 W/kg for 10 minutes of scanning.

In this non-clinical testing with duration of 10 minutes with EPI (endoplanar imaging) sequences, the GIMMI Aneurysm Clips system produced no temperature rise and no movement.

The test was performed in a SIEMENS MAGNETOM MAESTRO CLASS SYMPHONY MR scanner with a field strength of 1.5 Tesla.

MR image quality may be compromised if the area of interest is in the exact same area or relatively close to the position of the GIMMI Aneurysm Clips system. Therefore, it may be necessary to optimize MR imaging parameters for the presence of this metallic implant.

Image /page/1/Picture/23 description: The image shows a triangle with the letters "MR" inside. To the right of the triangle, the text "= MR CONDITIONAL" is displayed. The image appears to be a symbol or label indicating a specific condition or classification related to "MR".

2

Abbreviated 510(k)

K081640

5. SUMMARY of Safety and Effectiveness as required by Section 807.92 (c))

5.1 Submitter

GIMMI GmbH Carl-Zeiss-Str. 6 D-78532 Tuttlingen / Germany

Phone: +49-7461-96590.0 Fax: +49-7461-96590.33 E-mail: info@gimmi.de / u.henzler@gimmi.de

5.2 Contact Person

Scanlan International Mr. Kenneth Blake Vice President One Scanlan Plaza Saint Paul, Minnesota 55107

Phone: 651-298-0997 651-298-0018 Fax E-mail BlakeK@SurgicalTechnologies.com

5.3 Date Summary Prepared (807-92(a)(1)) (a))

June 5, 2008

5.4 Devices Names (807.92 (a)(1))

Yasargil Clip / Applying Forceps Proprietary Name:

Common Name: Aneurysm Clip / Clip Applier

Clip, Aneurysm / Applier, Aneurysm Clip Classification Names

Product CodeRegulation #ClassClassification Name
84 HCH882.5200IIClip, Aneurysm
84 HCI882.4175IIApplier, Aneurysm Clip

3

Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized eagle with three lines representing its body and wings. The eagle is facing to the right. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES · USA" is arranged in a circular pattern around the eagle.

MAY - 6 2009

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Public Health Service

Gimmi GmbH % Scanlan International Mr. Ken Blake One Scanlan Plaza Saint Paul, Minnesota 55107

Re: K081640

Trade/Device Name: GIMMI Aneurysm Clips and Applying Forceps Regulation Number: 21 CFR 882.5200 Regulation Name: Aneurysm clip Regulatory Class: II Product Code: HCH Dated: March 26, 2009 Received: March 30, 2009

Dear Mr. Blake:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements-as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

4

Page 2 - Mr. Ken Blakc

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding of adverse events under the MDR regulation (21 CFR Part 803), please contact the CDRH/Office of Surveillance and Biometrics/Division of Postmarket Surveillance at (240) 276-3464. For more information regarding the reporting of adverse events, please go to http://www.fda.gov/cdrh/mdr/.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

Neil R.P. Ogles
Mark N. Mellon for

Mark N. Melkerson Division of Surgical, Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

5

Abbreviated 510(k)

510(k) Number

GIMMI Aneurysm Clips and Applying Forceps Device Name 84 HCI / 84HCH, 882.4175 + 882.5200

Classification

Class II

Indications for Use

Permanent GIMMI Aneurysm Clips (Yasargil) and vessel clips are intended for Permanent occlusion of blood vessels and cerebral aneurysms. Likewise, temporary permianent occlusion of blood vessel clips are intended for temporary occlusion Gilvilli Aneurysin Olips (Tabargi) and cerebral aneurysms. They are also intended to be applied exclusively with the corresponding Clip Appliers.

Prescription Use (Part 21 CFR 801 Subpart D) AND/OR

Over-The-Counter Use (21 CFR 807 Subpart C)

.

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Daniel Keane for mxm
(Division Sign-Off)

Division of Surgical, Orthopedic, and Restorative Devices

510(k) Number K081640

Page 1 of __